Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© Springer Science+Business Media Dordrecht 2015. The kinesin-6 or mitotic kinesin (MKLP) family comprises three members in human cells: MKLP1 (KIF23), MKLP2 (KIF20A), and MPP1 (KIF20B). All three members have been characterised primarily because of their role in cell division, where they contribute to the regulation of the cytokinetic machinery as cells exit mitosis. Here we discuss the mechanisms by which MKLP1, MKLP2 and MPP1 regulate events during cell division and in post-mitotic tissues, highlighting common themes and points of difference. We also outline the ways they are dysregulated in human cancers. Finally we discuss the different ways kinesin-6 family members are being targeted to develop novel chemotherapy and immunotherapy strategies for treating human cancers.

Original publication





Book title

Kinesins and Cancer

Publication Date



193 - 222